Subscribe to RSS

DOI: 10.1055/s-0045-1811937
Treatment of Osteoid Osteoma: How to Optimize Impedance during Radiofrequency Ablation

Abstract
Introduction
Osteoid osteomas (OOs) are benign bone lesions that predominantly affect young individuals and are characterized by persistent, nocturnally exacerbated pain, which typically responds to nonsteroidal anti-inflammatory drugs (NSAIDs). While traditional surgical excision was once the standard treatment, percutaneous CT-guided radiofrequency ablation (RFA) has emerged over the past decades as the preferred minimally invasive approach.
Objectives
This article explores the technical aspects of RFA in OO treatment, with a particular focus on the challenges posed by elevated impedance during the procedure and strategies for optimization.
Materials and Methods
The RFA procedure involves precise CT-guided placement of an RF electrode within the nidus, followed by thermal ablation at 90°C for 5 to 6 minutes. Procedural technical success is determined by achieving effective coagulation necrosis, indicated by stable impedance values (350–400 ohms) and the occurrence of a “roll-off” effect, as set by the manufacturer. However, abnormally high impedance can hinder energy delivery, compromising treatment efficacy.
Results
Elevated impedance commonly arises due to electrode misplacement, contact with cortical bone or the sclerotic rim of the OO, or tissue charring around the electrode tip. Strategies to mitigate these issues include meticulous electrode positioning, incremental energy delivery, continuous temperature monitoring, and techniques such as repositioning the electrode, cleaning or replacing the radiofrequency system, “overdrilling,” or saline injection to enhance conductivity.
Conclusion
Managing impedance variations is crucial for optimizing technical RFA outcomes in OO treatment. By understanding and addressing impedance-related challenges, interventional radiologists can improve procedural success, minimize complications, and enhance patient outcomes in this minimally invasive approach.
Data Availability Statement
Data are available to share on request.
Patient's Consent
Consent to participate was obtained.
Publication History
Article published online:
16 September 2025
© 2025. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Boscainos PJ, Cousins GR, Kulshreshtha R, Oliver TB, Papagelopoulos PJ. Osteoid osteoma. Orthopedics 2013; 36 (10) 792-800
- 2 Bianchi G, Zugaro L, Palumbo P. et al. Interventional radiology's osteoid osteoma management: percutaneous thermal ablation. J Clin Med 2022; 11 (03) 723
- 3 Refaat R, Niazi G. Factors affecting time to pain relief in patients with osteoid osteoma treated by computed tomography (CT)-guided percutaneous radiofrequency ablation (RFA). Egypt J Radiol Nucl Med 2015; 46 (02) 397-404
- 4 Simm RJ. The natural history of osteoid osteoma. Aust N Z J Surg 1975; 45 (04) 412-415
- 5 Golding JS. The natural history of osteoid osteoma; with a report of twenty cases. J Bone Joint Surg Br 1954; 36-B (02) 218-229
- 6 Bottner F, Roedl R, Wortler K, Grethen C, Winkelmann W, Lindner N. Cyclooxygenase-2 inhibitor for pain management in osteoid osteoma. Clin Orthop Relat Res 2001; (393) 258-263
- 7 Carpintero-Benitez P, Aguirre MA, Serrano JA, Lluch M. Effect of rofecoxib on pain caused by osteoid osteoma. Orthopedics 2004; 27 (11) 1188-1191
- 8 Kneisl JS, Simon MA. Medical management compared with operative treatment for osteoid-osteoma. J Bone Joint Surg Am 1992; 74 (02) 179-185
- 9 National Institute for Clinical Excellence. Computed tomography-guided thermocoagulation of osteoid osteoma. National Institute for Clinical Excellence Web site. Interventional procedures guidance. Reference number:IPG53. Published: 24 March 2004 . Accessed September 1, 2025 at: https://www.nice.org.uk/guidance/ipg53/chapter/1-Recommendations
- 10 Uldin H, Kanbour I, Patel A, Botchu R. Image-guided musculoskeletal interventional radiology in the personalised management of musculoskeletal tumours. J Pers Med 2024; 14 (12) 1167
- 11 Al-Omari MH, Ata KJ, Al-Muqbel KM, Mohaidat ZM, Haddad WH, Rousan LA. Radiofrequency ablation of osteoid osteoma using tissue impedance as a parameter of osteonecrosis. J Med Imaging Radiat Oncol 2012; 56 (04) 384-389
- 12 Hoffmann R-T, Jakobs TF, Kubisch CH. et al. Radiofrequency ablation in the treatment of osteoid osteoma-5-year experience. Eur J Radiol 2010; 73 (02) 374-379
- 13 Cantwell CP, Eustace S. An unusual complication of radiofrequency ablation treatment of osteoid osteoma. Clin Orthop Relat Res 2006; 451 (451) 290-291 , author reply 291–292
- 14 Lanza E, Thouvenin Y, Viala P. et al. Osteoid osteoma treated by percutaneous thermal ablation: when do we fail? A systematic review and guidelines for future reporting. Cardiovasc Intervent Radiol 2014; 37 (06) 1530-1539
- 15 Singh DK, Katyan A, Kumar N, Nigam K, Jaiswal B, Misra RN. CT-guided radiofrequency ablation of osteoid osteoma: established concepts and new ideas. Br J Radiol 2020; 93 (1114) 20200266
- 16 Chen B, Shi Y, Li J. et al. Tissue recognition based on electrical impedance classified by support vector machine in spinal operation area. Orthop Surg 2022; 14 (09) 2276-2285